A major contributor to this article appears to have a close connection with its subject. (November 2018) |
Dipak K Banerjee is an Indian scholar of Biochemistry. He is a professor at the University of Puerto Rico and chairman of the company he established, DIC India Ltd.[1]
Banerjee received his Bachelor of Science, Master of Science, and Doctor of Philosophy in Chemistry from the University of Calcutta.[2] He has authored and co-authored articles on Glycosyltransferases[3] and Breast cancer cells[4] and is a fellow member of the American Association for the Advancement of Science.[2][5]
References edit
- ^ "Dipak Kumar Banerjee, Shristi Infras Dev Corp LTD: Profile and Biography". www.bloomberg.com. Retrieved 1 June 2023.
- ^ a b "Dr. Dipak K. Banerjee". Department of Biochemistry. Retrieved 11 October 2018.
- ^ Banerjee, Dipak K. (September 2012). "N-glycans in cell survival and death: cross-talk between glycosyltransferases". Biochimica et Biophysica Acta (BBA) - General Subjects. 1820 (9): 1338–1346. doi:10.1016/j.bbagen.2012.01.013. ISSN 0006-3002. PMC 3499948. PMID 22326428.
- ^ Serrano-Negrón, Jesús E.; Zhang, Zhenbo; Rivera-Ruiz, Andrea P.; Banerjee, Aditi; Romero-Nutz, Eva C.; Sánchez-Torres, Neysharie; Baksi, Krishna; Banerjee, Dipak K. (1 February 2018). "Tunicamycin-induced ER stress in breast cancer cells neither expresses GRP78 on the surface nor secretes it into the media". Glycobiology. 28 (2): 61–68. doi:10.1093/glycob/cwx098. ISSN 1460-2423. PMC 6192387. PMID 29206917.
- ^ "Elected Fellows". American Association for the Advancement of Science. Retrieved 22 October 2018.